Key Highlights

• For the year to 30 June 2026, Bega reported Revenue of A$3,774.6 million, up 6.7 per cent.

• Net Debt was A$151.6 million, higher than the previous year because of Capital Investment and restructuring spending.

• FY2027 guidance is normalised EBITDA of A$240 million to A$245 million, supported by Demand for protein and encouraging international sales, particularly in Southeast Asia.

• A miss against the A$240 million to A$245 million range would test the credibility of the FY2031 target.

Why is a dairy and food company guiding to higher Earnings after a year in which it returned to profit? Bega Cheese's (ASX:BGA) FY2026 result, announced on 20 August 2026, showed statutory net profit after tax of A$54.8 million, compared with a loss the year before. Management attributes the improvement partly to branded product growth, better integration of ingredients, and cost savings from exiting primary peanut processing. The company guided to FY2027 normalised EBITDA of A$240 million to A$245 million, which is a management expectation, not an outcome.

The central development: a return to profit

For the year to 30 June 2026, Bega reported revenue of A$3,774.6 million, up 6.7 per cent. Statutory EBITDA, or earnings before interest, tax, Depreciation and amortisation, was A$202.3 million, up 22 per cent. Normalised EBITDA, which excludes items management regards as non-recurring, was A$225.6 million, up 12 per cent. Statutory net profit after tax was A$54.8 million.

Investors should be aware that restructuring costs, such as those that accompany exiting a processing activity, can recur if a company keeps rationalising its operations.

The result is helped by a lower base: the improvement from a loss to profit is a recovery as well as growth. A normalised measure is a better guide to underlying trend than a statutory swing, although the company defines the normalisation.

Business model and segments

Bega is an Australian dairy and food group. In Branded, performance came from yoghurt, milk beverages and international sales, supported by demand for protein and health-focused products. Exiting primary peanut processing delivered cost savings. In Bulk, better integration of ingredients into the branded range and improved Commodity conditions lifted performance.

The company's strategy, visible in these descriptions, is to turn more of its milk and ingredients into branded and value-added products, which can reduce exposure to commodity price swings, though not remove it.

Dividends and balance sheet

The final Dividend was 7.5 cents per share, fully franked, and total FY2026 dividends were 14.5 cents per share. The prior-year comparison was not available. Net debt was A$151.6 million, higher than the previous year because of capital investment and restructuring spending.

Readers should check the Appendix 4E for the company's own measure.

Outlook and targets

FY2027 guidance is normalised EBITDA of A$240 million to A$245 million, supported by demand for protein and encouraging international sales, particularly in Southeast Asia.

The company also set a target for FY2031 normalised EBITDA of more than A$310 million. It is a company aspiration and should be weighed accordingly. Reaching A$310 million from A$225.6 million would require compound growth, which readers can compute, but milestones along the way matter more than the end point.

Sector and competitive position

Bega competes in dairy and packaged foods with large multinational and domestic brands, and sells to major supermarkets, whose bargaining power can pressure margins. Protein and health-focused products are a growth area, according to the company's commentary, which also points to international sales in Southeast Asia as a driver.

Investors should therefore treat the guidance range as dependent on conditions that can change within a year.

Risks and developments to monitor

Key risks include milk Supply and farmgate price movements, commodity price Volatility in bulk products, retail pricing pressure, restructuring costs, execution of capital projects and currency. Dependence on international sales in Southeast Asia adds exposure to demand and trade conditions in those markets. A miss against the A$240 million to A$245 million range would test the credibility of the FY2031 target.

Items to watch include the first-half FY2027 result, the trend in normalised EBITDA relative to guidance, net debt as capital investment continues, further portfolio rationalisation and disclosures about milk costs and branded margins.